DK0862554T3 - Aromatiske carboxylsyreestere, fremstillingen deraf og anvendelsen deraf som lægemiddel - Google Patents

Aromatiske carboxylsyreestere, fremstillingen deraf og anvendelsen deraf som lægemiddel

Info

Publication number
DK0862554T3
DK0862554T3 DK96934302T DK96934302T DK0862554T3 DK 0862554 T3 DK0862554 T3 DK 0862554T3 DK 96934302 T DK96934302 T DK 96934302T DK 96934302 T DK96934302 T DK 96934302T DK 0862554 T3 DK0862554 T3 DK 0862554T3
Authority
DK
Denmark
Prior art keywords
alkyl
hydrogen
drug
preparation
aromatic carboxylic
Prior art date
Application number
DK96934302T
Other languages
English (en)
Inventor
Michael Klaus
Peter Mohr
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK0862554T3 publication Critical patent/DK0862554T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK96934302T 1995-11-16 1996-11-05 Aromatiske carboxylsyreestere, fremstillingen deraf og anvendelsen deraf som lægemiddel DK0862554T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH324995 1995-11-16
EP96934302A EP0862554B1 (de) 1995-11-16 1996-11-05 Aromatische carbonsäureester, ihre herstellung und verwendung als heilmittel

Publications (1)

Publication Number Publication Date
DK0862554T3 true DK0862554T3 (da) 2005-02-14

Family

ID=4251881

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96934302T DK0862554T3 (da) 1995-11-16 1996-11-05 Aromatiske carboxylsyreestere, fremstillingen deraf og anvendelsen deraf som lægemiddel

Country Status (16)

Country Link
US (2) US5726191A (da)
EP (1) EP0862554B1 (da)
JP (1) JP3061865B2 (da)
KR (1) KR100286190B1 (da)
CN (1) CN1137883C (da)
AT (1) ATE280159T1 (da)
AU (1) AU705849B2 (da)
BR (1) BR9611525A (da)
CA (1) CA2237313C (da)
DE (1) DE59611123D1 (da)
DK (1) DK0862554T3 (da)
ES (1) ES2230568T3 (da)
MX (1) MX9803829A (da)
PT (1) PT862554E (da)
TR (1) TR199800870T2 (da)
WO (1) WO1997018192A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2178B1 (en) 1999-10-19 2003-04-23 اف . هوفمان لاروش ايه جي Treatment of invasive diseases, using selected anti-PAR materials
EP1930005A1 (en) 2001-01-19 2008-06-11 Johnson and Johnson Consumer Companies, Inc. Stabilized formulation of selective ligands of retinoic acid gamma-receptors
WO2002074310A2 (en) * 2001-01-19 2002-09-26 Johnson & Johnson Consumer Companies, Inc. Stabilized formulation of selective ligands of retinoic acid gamma-receptors
US20030166732A1 (en) * 2002-02-27 2003-09-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
US20060189893A1 (en) * 2005-01-06 2006-08-24 Diamics, Inc. Systems and methods for detecting abnormal cells
US20060161076A1 (en) * 2005-01-06 2006-07-20 Diamics, Inc. Systems and methods for collection of cell clusters
BR112013004685B1 (pt) 2010-09-01 2021-09-21 Thomas Jefferson University Uso de um agonista de receptor gama de ácido retinóico (rar?) para reparação e regeneração muscular

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3860716A (en) * 1971-04-06 1975-01-14 Smithkline Corp Methods and pharmaceutical compositions for inhibiting gluconeogenesis
DK158947C (da) * 1982-07-06 1991-01-21 Hoffmann La Roche Tetrahydronaphthalin-,benzofuran- og benzothiophenderivater, fremstilling og anvendelse deraf samt rodenticid indeholdende saadanne derivater
US4567184A (en) * 1982-12-01 1986-01-28 Usv Pharmaceutical Corporation Certain aryl or hetero-aryl derivatives of 1-hydroxy-pentane or 1-hydroxy-hexane which are useful for treating inflammation and allergies
EP0170105B1 (en) * 1984-07-07 1990-10-17 Koichi Prof. Dr. Shudo Benzoic acid derivatives
FR2649977B1 (fr) * 1989-07-18 1991-10-04 Cird Esters bi-aromatiques, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
JPH06507178A (ja) * 1991-09-24 1994-08-11 ファイザー　インク レチノイド類、並びに皮膚疾患及び白血病の治療におけるそれらの使用法
EP0617020A1 (en) * 1992-04-02 1994-09-28 Shudo, Koichi, Prof. Dr. Carboxylic acid derivatives having retinoic acid-like activity
ES2139063T3 (es) * 1993-01-11 2000-02-01 Ligand Pharm Inc Compuestos que tienen selectividad por receptores de retinoides x.

Also Published As

Publication number Publication date
WO1997018192A1 (de) 1997-05-22
TR199800870T2 (xx) 1998-07-21
CN1202154A (zh) 1998-12-16
MX9803829A (es) 1998-09-30
JPH11500452A (ja) 1999-01-12
CA2237313C (en) 2006-04-25
ATE280159T1 (de) 2004-11-15
JP3061865B2 (ja) 2000-07-10
BR9611525A (pt) 1999-07-13
AU705849B2 (en) 1999-06-03
EP0862554A1 (de) 1998-09-09
PT862554E (pt) 2005-01-31
KR100286190B1 (ko) 2001-04-16
AU7275996A (en) 1997-06-05
CA2237313A1 (en) 1997-05-22
CN1137883C (zh) 2004-02-11
EP0862554B1 (de) 2004-10-20
ES2230568T3 (es) 2005-05-01
DE59611123D1 (de) 2004-11-25
KR19990067645A (ko) 1999-08-25
US5726191A (en) 1998-03-10
US5958956A (en) 1999-09-28

Similar Documents

Publication Publication Date Title
MA23170A1 (fr) Procede de preparation d'un nouveau compose .
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
MX9803753A (es) Acidos alfa-iminohidroxamicos y -carboxilicos n-sustituidos ciclicos y heterociclicos.
ATE359264T1 (de) Sulfonierte aminosäurederivate und metalloproteinase-inhibitoren, die diese enthalten
CA2268886A1 (en) Aminothiophenecarboxamides
TNSN95076A1 (fr) Forme de dosage ii d'unite multiple en comprime
IL135921A (en) Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
AU8141991A (en) Substituted sulfonamides, process of preparation and medicines containing same
DK0862554T3 (da) Aromatiske carboxylsyreestere, fremstillingen deraf og anvendelsen deraf som lægemiddel
DE69611452D1 (de) Benzothiophenderivate
CA2231176A1 (en) Long active composition for rectal administration
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
DK0601345T3 (da) Lægemiddel Indeholdende en imidazol-l-yl-forbindelse
NO950360D0 (no) Nytt legemiddel som inneholder 3-fenylsulfonyl-3,7-diazabisyklo[3,3,1Ånonan-forbindelser
TR199801196T2 (xx) Biyolojik aktif benzotiyazolon etanaminler.
NO971261L (no) Kinoksalin-derivater nyttige innen terapi
ES2147499A1 (es) Derivados de acidos carboxilicos, metodo para su elaboracion y agentes terapeuticos que contienen estos compuestos.
IT1276710B1 (it) Derivati dell'acido fosfinico ad attivita' inibitrice delle metallopeptidasi
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
WO1995006473A3 (en) Medical use of polysulfonic acid compound
WO2002074310A3 (en) Stabilized formulation of selective ligands of retinoic acid gamma-receptors
IT1282289B1 (it) 17-idrossiimminoalchil e 17-idrossiimminometilalchenil ciclopentaperidrofenantreni attivi sul sistema cardiovascolare,
IT1217589B (it) Agente antiinfiammatorio per la terapia dell'ipertrofia prostatica,sua preparazione e relative composizioni farmaceutiche
MX9801698A (es) Nuevos derivados del acido carboxilico, su obtencion y uso.
HUP9902307A2 (hu) Új, áthidalt gyűrűs aminosavak, előállításuk és intermedierjeik